Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director departure
Quarterly results
CC transcript
MEDIFAST INC (MED) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/27/2023 8-K Quarterly results
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/07/2023 8-K Quarterly results
Docs: "Medifast Announces Second Quarter 2023 Financial Results"
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
06/01/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Medifast Enhances “Fuel for the Future” Program to Position the Business for Long-term Sustainable Growth"
05/01/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/01/2023 8-K Quarterly results
05/01/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/01/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/01/2023 ARS Form ARS - Annual Report to Security Holders:
04/20/2023 8-K Quarterly results
03/16/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Medifast Announces Quarterly Dividend"
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/26/2023 SC 13G/A BlackRock Inc. reports a 16.9% stake in MEDIFAST INC
12/08/2022 8-K Quarterly results
11/03/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/03/2022 8-K Quarterly results
09/08/2022 8-K Other Events  Interactive Data
08/03/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/03/2022 8-K Quarterly results
Docs: "Medifast Announces Second Quarter 2022 Financial Results and Updated Outlook"
06/16/2022 8-K Quarterly results
06/03/2022 8-K Quarterly results
06/01/2022 8-K Quarterly results
05/02/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/02/2022 8-K Quarterly results
04/21/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/21/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/17/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Medifast, Inc. Announces Quarterly Dividend"
02/23/2022 10-K Annual Report for the period ended December 31, 2021
02/23/2022 8-K Quarterly results
Docs: "Medifast, Inc. Announces Fourth Quarter and Full Year 2021 Financial Results"
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2022 SC 13G/A VANGUARD GROUP INC reports a 12.9% stake in Medifast Inc.
01/27/2022 SC 13G/A BlackRock Inc. reports a 17.2% stake in MEDIFAST INC
01/25/2022 SC 13G/A BlackRock Inc. reports a 17.2% stake in MEDIFAST INC
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy